Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| METLIFE INCMET · Entity 488 | EVP - Gl. Chief Marketing Off. | June 14, 2021 | June 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,610.3691 |
Reported balance
After 2025-02-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-14 · Grant · Acquired 111.336 · Balance 13,610.3691 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,733.5856 |
Reported balance
After 2025-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-09 · Grant · Acquired 123.2165 · Balance 13,733.5856 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,877.6604 |
Reported balance
After 2025-08-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-08-29 · Grant · Acquired 144.0748 · Balance 13,877.6604 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,039.5751 |
Reported balance
After 2025-11-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-06 · Grant · Acquired 161.9147 · Balance 14,039.5751 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,677.4328 |
Reported balance
After 2025-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-12-31 · Grant · Acquired 1,637.8577 · Balance 15,677.4328 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
METLIFE INC
Report date June 14, 2021 · Filed June 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,956 |
Reported balance
After 2021-06-14 transaction · row 1
1 source rowRow 1 · 2021-06-14 · Grant · Acquired 178 · Balance 56,956 F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. |
Filing footnotes · ownership attribution and instrument terms
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,781 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 3,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,941 Underlying: Common Stock · 3,941 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 11,823 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,823 Underlying: Common Stock · 11,823 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 249 | $47.58 | $11,847.42 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,446 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the deferred shares. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 9,755 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,695 F1 · price: Shares earned from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 46.3958 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,260.9407 Underlying: Common Stock · 46.3958 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,214.5449 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:07 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 111 | $50.38 | $5,592.18 |
DisclosureSEC source: 0001099219-19-000265 · wf-form4_157662041646747.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,940 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 44.9135 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,201.4547 Underlying: Common Stock · 44.9135 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 114 | $48.37 | $5,514.18 |
DisclosureSEC source: 0001099219-19-000179 · wf-form4_156875412237325.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,830 F1 · kind: Represents imputed reinvested dividends in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| August 16, 2019 Filed Jan 3, 2020 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 40.2935 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,156.5412 Underlying: Common Stock · 40.2935 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:06 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 113 | $48.51 | $5,481.63 |
DisclosureSEC source: 0001099219-19-000082 · wf-form4_156081275003561.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,715 F1 · kind: Represents imputed reinvested dividends in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| May 10, 2019 Filed Jan 3, 2020 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 39.3671 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,116.2478 Underlying: Common Stock · 39.3671 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · derivative · entry 9 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,638 Underlying: Common Stock · 1,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 505 | $45.66 | $23,058.30 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 6 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,149 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 5 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · derivative · entry 8 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · shares: Includes 189 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F5 · derivative.underlying_shares: Includes 189 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 2,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · derivative · entry 7 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,429 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 259 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F3 · derivative.underlying_shares: Includes 259 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 680 | $45.55 | $30,974.00 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 4 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,335 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 929 | $45.55 | $42,315.95 |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,237 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 2,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017152 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 4,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,097 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,097 Underlying: Common Stock · 12,097 shares Expires 2029-02-25 F2 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 12,776 | $44.65 | $570,448.40 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,513 F1 · kind: The Reporting Person acquired these deferred shares from the 2016-2018 Performance Shares pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife Leadership Deferred Compensation Plan, under which Executive Officers may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| February 26, 2019 Filed May 1, 2019 01:27 UTC Amendment | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 323 | $44.65 | $14,421.95 |
DisclosureSEC source: 0001209191-19-026692 · doc4a.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,190 F1 · kind: The Reporting Person earned 12,776 shares from 2016-2018 Performance Shares pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. She deferred those shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such stock for a specific period of time. The Company withheld 323 shares to satisfy withholding for FICA and Medicare taxes. These withheld shares were inadvertently omitted from the original, timely February 28, 2019 report of the Reporting Person's deferred share acquisition. F2 · balance_after: As a result of the inadvertent omission described in footnote (1), the amount of securities beneficially owned by the Reporting Person was incorrectly stated on the report filed on February 28, 2019. The amount in Table I box 5 of this report is the amount of ownership immediately following the transaction reported on this form. By this note, this report also corrects the amount of securities beneficially owned following each of the reported transactions in box 5 of Table I of the Reporting Person's report filed on March 5, 2019 to 28,619; 27,690; 29,468; 28,788; 30,107; and 29,602, respectively. Read SEC document |
| February 08, 2019 Filed Jan 3, 2020 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 37.2482 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,076.8807 Underlying: Common Stock · 37.2482 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 963.0341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000385 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,039.6325 Underlying: Common Stock · 963.0341 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 16, 2018 Filed Jan 3, 2019 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 29.9027 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000385 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,076.5984 Underlying: Common Stock · 29.9027 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 17, 2018 Filed Jan 3, 2019 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 32.6273 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000385 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,046.6957 Underlying: Common Stock · 32.6273 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 11, 2018 Filed Jan 3, 2019 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 39.6173 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000385 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,014.0684 Underlying: Common Stock · 39.6173 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 3,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · derivative · entry 8 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,957 Underlying: Common Stock · 3,957 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F8 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. F8 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,866 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · derivative · entry 7 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,866 Underlying: Common Stock · 11,866 shares Expires 2028-03-01 F7 · derivative.exercise_date: The options become exercisable in three installments on March 2, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · derivative · entry 6 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,559 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · shares: Includes 189 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F6 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F6 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F5 · derivative.underlying_shares: Includes 189 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 2,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,429 Underlying: Common Stock · 2,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 258 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F3 · derivative.underlying_shares: Includes 258 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 947 | $45.50 | $43,088.50 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · nonDerivative · entry 4 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,737 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · nonDerivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,117 | $45.50 | $50,823.50 |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:40 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 2,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017295 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 09, 2018 Filed Jan 3, 2019 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 32.2319 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000385 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,974.4511 Underlying: Common Stock · 32.2319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 17,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 1,893 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units were granted on January 12, 2015, and vested on January 12, 2018. F4 · derivative.expiration_date: The Restricted Stock Units were granted on January 12, 2015, and vested on January 12, 2018. F3 · derivative.underlying_shares: Includes 1,893 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 7,412 | $53.33 | $395,281.96 |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,596 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 17,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,008 F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,002.0689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000439 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,942.2192 Underlying: Common Stock · 1,002.0689 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 13, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 24.3505 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000439 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,940.1503 Underlying: Common Stock · 24.3505 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 04, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 24.3056 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000439 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,915.7998 Underlying: Common Stock · 24.3056 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 05, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 23.2867 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000439 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,891.4942 Underlying: Common Stock · 23.2867 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 2,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017502 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339 Underlying: Common Stock · 2,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 918 | $54.33 | $49,874.94 |
DisclosureSEC source: 0001209191-17-017502 · doc4.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,251 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 2,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-017502 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.